Vaccines
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
307
NCT04227210
Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 14, 2020
Completion: Aug 27, 2020
NCT04444284
Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositive Children
Start: Jun 9, 2020
Completion: May 7, 2021
NCT04690335
Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine
Phase: Phase 2
Start: Dec 29, 2020
Completion: Sep 9, 2021
NCT04798001
Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults
Start: Apr 12, 2021
Completion: Oct 31, 2022
NCT04909021
Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months
Start: Jun 3, 2021
Completion: Oct 31, 2023
Loading map...